Nicholas Murgolo
Merck & Co., Inc., Rahway, NJ, USA (United States)
ORCID: 0000-0001-7094-3344Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus”.
Dereje A. Negatu, Abdellatif El Marrouni, Randy R. Miller, Christopher W. Boyce, Nicholas Murgolo +7 more
Gregory C. Adam, John A. Howe, Vijeta Sharma, Matthew Zimmerman, Enriko Dolgov +26 more
Dereje A. Negatu, Abdellatif El Marrouni, Randy R. Miller, Christopher W. Boyce, Nicholas Murgolo +7 more
Gregory C. Adam, John A. Howe, Vijeta Sharma, Matthew Zimmerman, Enriko Dolgov +26 more
Josephine Palandri, Manuel de Lera Ruiz, Wendy Bailey, Christopher W. Boyce, Andrew Danziger +34 more